Boston, Mass. – The World Orphan Drug Congress brings together leading pharmaceutical and biotech companies, government and regulatory authorities, patient advocacy groups, payers, investors and solution providers. The conference is a place to meet and brainstorm ways to advance orphan drug development and improve access to life-saving therapies.
Highlighted agenda topics include:
- Transformative policies and strategies for orphan drug accessibility
- NIH as your technology development and commercialization partner
- Current best practices for diversity in clinical trials
- How to successfully achieve reimbursement in rare diseases: From inception to submission
- Strategies to save time and cost in rare disease drug development
- Access for rare disease patients in Europe and beyond
- Commercialization in rare disease
- Understanding the implications of state policies on patient access
- Using biomarkers to accelerate development of disease modifying therapies for rare disease
- Industry perspectives: Partnering in the rare disease space
For further information about the congress, including registration and abstract submission, please click here.
Congress details
When: April 23-25, 2024
Venue: Boston Convention and Exhibition Center – 415 Summer Street, Boston, MA 02210